Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies

Bo Wang(Peking University), Sailimai Man(Peking University), Cheng Jin(Stanford University), Lu Xu(Jianghan University), Siyan Zhan(Peking University), Lian Liu(Qilu Hospital of Shandong University), Qihuan Li
BMC Cancer
October 21, 2020
Cited by 13


Related Papers